Segment Information

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Segment Information

Segment Information

We periodically evaluate our application of accounting guidance for reportable segments and disclose information about reportable segments based on the way management organizes the enterprise for making operating decisions and assessing performance. We report our business under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment includes our United States distribution business (Medical Distribution), outsourced logistics and value-added services business, and Global Products which manufactures and sources medical surgical products through our production and kitting operations. The Patient Direct segment includes our home healthcare businesses (Byram and Apria).

We evaluate the performance of our segments based on their operating income excluding intangible amortization and acquisition-related and exit and realignment charges that, either as a result of their nature or size, would not be expected to occur as part of our normal business operations on a regular basis. Segment assets exclude inter-segment account balances as we believe their inclusion would be misleading and not meaningful.

The following tables present financial information by segment:

	Three Months Ended  June 30,				Six Months Ended  June 30,
	2022		2021		2022		2021
Net revenue:
Products & Healthcare Services	$	1,927,388	$	2,255,820	$	4,061,429	$	4,365,265
Patient Direct	572,627		233,640		845,538		450,729
Consolidated net revenue	$	2,500,015	$	2,489,460	$	4,906,967	$	4,815,994
Operating income:
Products & Healthcare Services	$	61,243	$	101,229	$	150,325	$	251,647
Patient Direct	52,332		14,305		68,125		26,569
Intangible amortization	(30,888)		(10,026)		(41,156)		(20,052)
Acquisition-related and exit and realignment charges	(7,602)		(8,624)		(41,150)		(14,587)
Consolidated operating income	$	75,085	$	96,884	$	136,144	$	243,577
Depreciation and amortization:
Products & Healthcare Services	$	19,209	$	18,847	$	38,203	$	38,007
Patient Direct	53,952		3,753		59,083		7,494
Consolidated depreciation and amortization	$	73,161	$	22,600	$	97,286	$	45,501
Capital expenditures:
Products & Healthcare Services	$	18,418	$	11,806	$	29,061	$	18,270
Patient Direct	36,320		252		36,638		411
Consolidated capital expenditures	$	54,738	$	12,058	$	65,699	$	18,681

	June 30, 2022		December 31, 2021
Total assets:
Products & Healthcare Services	$	2,968,089	$	3,012,303
Patient Direct	2,530,783		468,536
Segment assets	5,498,872		3,480,839
Cash and cash equivalents	56,406		55,712
Consolidated total assets	$	5,555,278	$	3,536,551

The following table presents net revenue by geographic area, which were attributed based on the location from which

we ship products or provide services.

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Net revenue:
United States	$	2,376,573	$	2,336,673	$	4,638,592	$	4,519,428
International	123,442		152,787		268,375		296,566
Consolidated net revenue	$	2,500,015	$	2,489,460	$	4,906,967	$	4,815,994